TABREZ NOORANI: Open Payments
NPI 1275780520 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 17 payments from 10 companies in 2025. Trend: 2023 $394 · 2024 $415 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $64 |
| Lilly USA, LLC | 3 | $53 |
| ABBVIE INC. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Exact Sciences Corporation | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Medtronic, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $22 |
| Amgen Inc. | 1 | $17 |
Products named: MOUNJARO, Wegovy, VRAYLAR, AIRSUPRA, The Cologuard Plus Collection Kit, REXULTI, Kerendia, INTELLIS ADAPTIVESTIM.
Industry payments across FL — which companies pay providers there.
